| This study identifies the proto-oncogene RET as a novel component of the foetal male germ cell development pathway. | None |
| Genetic variation of the RET-protooncogene and NRG1 is involved in the risk of Hirschsprung disease development in the Thai population. | None |
| 95% of MEN 2B patients are associated with a point mutation in exon 16 (M918/T). A second point mutation at codon 883 has been found in 2%-3% of MEN 2B cases. RET proto-oncogene is also involved in neoplastic and non-neoplastic neurocristopathies. | None |
| Multiple endocrine neoplasias type 2B and RET proto-oncogene. | None |
| Lessons to be learned from the clinical management of a MEN 2A patient bearing a novel 634/640/700 mutation of the RET proto-oncogene. | None |
| A 34-year-old nulliparous patient presented with a history of MEN2A syndrome and mutation in c-RET proto-oncogene (codon 634, exon11, TGC to TAC) (patient_s mother also has history ofMEN2A syndrome). [case report] | None |
| [Human ret proto-oncogene]. | None |
| TFAP2C regulates expression of the RET proto-oncogene through five AP-2 regulatory sites in the RET promoter. | None |
| Correlation between multiple RET mutations and severity of Hirschsprung s disease. | None |
| The RET proto-oncogene is considered the major candidate gene for causing Hirschsprung_s disease. | None |
| RET proto-oncogene genetic screening of families with multiple endocrine neoplasia type 2 optimizes diagnostic and clinical management in China. | None |
| Novel tandem germline RET proto-oncogene mutations in a patient with multiple endocrine neoplasia type 2B: report of a case and a literature review of tandem RET mutations with in silico analysis. | None |
| The clinical spectrum of RET proto-oncogene mutations in codon 790. | None |
| Oncogenic RET kinase domain mutations perturb the autophosphorylation trajectory by enhancing substrate presentation in trans. | None |
| The RET receptor tyrosine kinase is crucial for normal development but also for oncogenesis. [review] | None |
| First reported case in Ireland of MEN2A due to a rare mutation in exon 8 of the RET oncogene. | None |
| [Multiple endocrine neoplasia type 2A caused by a p.C618R RET proto-oncogene mutation in a Chinese pedigree]. | None |
| Diagnostic correlation between RET proto-oncogene mutation, imaging techniques, biochemical markers and morphological examination in MEN2A syndrome: case report and literature review. | None |
| reports features of the largest known family in Turkey with the V804M-mutated RET proto-oncogene | None |
| A novel dual kinase function of the RET proto-oncogene negatively regulates activating transcription factor 4-mediated apoptosis. | None |